Darifenacin HBr

CAS No. 133099-07-7

Darifenacin HBr( UK 88525-04 )

Catalog No. M11319 CAS No. 133099-07-7

Darifenacin is a selective muscarinic receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 29 In Stock
50MG 39 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG 105 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Darifenacin HBr
  • Note
    Research use only, not for human use.
  • Brief Description
    Darifenacin is a selective muscarinic receptor antagonist.
  • Description
    Darifenacin is a selective muscarinic receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UK 88525-04
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    M3 mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    133099-07-7
  • Formula Weight
    505.45
  • Molecular Formula
    C28H31BrN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 117 mg/mL (230.56 mM)
  • SMILES
    C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moriya H, et al. Life Sci. 1999; 64(25):2351-8.
molnova catalog
related products
  • Acetamiprid

    Acetamiprid is a nicotinic acetylcholine receptor (nAChR) agonist. Acetamiprid is a neonicotinoid insecticide used worldwide. It is shown to be associated with neuromuscular and reproductive disorders. Acetamiprid decreases in body weight and mildly affected spermatogenesis.

  • TTNPB

    TTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.

  • TAE-1

    TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.